Adam Shlien

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Journal: Research square

Published: August 20, 2026

ROME, an Ancient Gene with a Novel Function in Vertebrates, Is a Key Modulator of Embryonal Development and Cancer Metastasis.

ROME, an Ancient Gene with a Novel Function in Vertebrates, Is a Key Modulator of Embryonal Development and Cancer Metastasis.

Journal: Cancer research communications

Published: January 22, 2026

An international framework for clinical translation of molecular classifiers in osteosarcoma.

An international framework for clinical translation of molecular classifiers in osteosarcoma.

Journal: NPJ precision oncology

Published: January 06, 2026

2025 Canadian Surgery Forum: Sept. 17-20, 2025.

2025 Canadian Surgery Forum: Sept. 17-20, 2025.

Journal: Canadian journal of surgery. Journal canadien de chirurgie

Published: December 09, 2025

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Journal: Molecular cancer therapeutics

Published: April 29, 2025

Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma.

Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma.

Journal: Nature genetics

Published: April 22, 2025

Prior therapy defines mutation profiles in childhood cancer at relapse.

Prior therapy defines mutation profiles in childhood cancer at relapse.

Journal: Nature

Published: March 03, 2025

Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines.

Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 09, 2025

Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencing.

Assessing the diagnostic impact of blood transcriptome profiling in a pediatric cohort previously assessed by genome sequencing.

Journal: NPJ genomic medicine

Published: December 06, 2024

Clinical utility of targeted RNA sequencing in cancer molecular diagnostics.

Clinical utility of targeted RNA sequencing in cancer molecular diagnostics.

Journal: Nature medicine

Published: November 22, 2024

DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.

DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.

Journal: Cell reports

Published: October 11, 2024

Showing 1-12 of 101

Last Updated: 09/26/2026